Source: Madeline Hholcombe, WRAL, 9/27/21

 Pfizer/BioNTech plans to ask for authorization of a Covid-19 vaccine for children under 12 soon, bringing the US one step closer to offering protection to a population that has grown particularly vulnerable as the fall season gets underway. "It is a question of days, not weeks," Pfizer Chairman and CEO Albert Bourla told ABC News Sunday about when the company will submit data on children ages 5 to 11 to the FDA for consideration.

For more of this story, click here.